American regulators have approved a new malaria drug aimed at
combatting a recurring strain of the disease.
It affects around eight and a half million people a year.
Nick Harper reports from New York.
IN: "The parasite.."
OUT: ...SOC"
DUR: 34 seconds
GENERIC: http://www.fsnradionews.com/feeds/0723malaria-nh.mp3
The latest short-form news audio from FSN Bureaus worldwide